Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × sacituzumab govitecan × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Urothelial Bladder Carcinoma 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Metastatic Urothelial Cancer 1 Lung Neoplasms 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1 Laryngeal Neoplasms 1 Klatskin Tumor 1 Hypopharyngeal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 4 Paclitaxel 3 Bevacizumab 3 trastuzumab deruxtecan 1 rucaparib 1 pembrolizumab 1 olaparib 1 niraparib 1 mirvetuximab soravtansine 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Nivolumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 Glucose 1 GEN-1 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡